Stock SANJIVIN SANJIVANI PARANTERAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sanjivani Paranteral Limited

Equities

SANJIVIN

INE860D01013

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:51 2024-05-17 EDT 		5-day change 1st Jan Change
184.2 INR -1.71% Intraday chart for Sanjivani Paranteral Limited -0.46% +2.25%
04-08 Sanjivani Parenterals CFO Steps Down MT
04-08 Sanjivani Paranteral Limited Announces Board Changes CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 32.38 28.49 51.32 93.48 654.9 414.2
Enterprise Value (EV) 1 611.1 506.9 537.7 552.3 711.4 436.1
P/E ratio -0.06 x -1.38 x -3 x 6.59 x 13.5 x 9.19 x
Yield - - - - - -
Capitalization / Revenue 0.18 x 0.11 x 0.31 x 0.37 x 2.14 x 1.17 x
EV / Revenue 3.36 x 2.02 x 3.29 x 2.2 x 2.32 x 1.23 x
EV / EBITDA -1.18 x -29.1 x -162 x 25.6 x 12.4 x 7.71 x
EV / FCF 4.79 x -30.8 x 40.1 x -30.3 x 10.8 x 10.1 x
FCF Yield 20.9% -3.25% 2.49% -3.3% 9.24% 9.91%
Price to Book -0.06 x -0.06 x -0.1 x -0.21 x -8.64 x -13.5 x
Nbr of stocks (in thousands) 5,898 5,898 5,898 8,498 9,998 9,998
Reference price 2 5.490 4.830 8.700 11.00 65.50 41.43
Announcement Date 10/21/18 10/14/19 9/7/20 9/6/21 9/7/22 9/6/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 182 251 163.6 251 306.1 354.9
EBITDA 1 -519.3 -17.42 -3.322 21.58 57.33 56.54
EBIT 1 -531.3 -29.13 -14.04 12.98 48.56 47.66
Operating Margin -291.91% -11.61% -8.59% 5.17% 15.86% 13.43%
Earnings before Tax (EBT) 1 -533.7 -22.97 -18.09 14.12 48.79 49.44
Net income 1 -530.6 -20.67 -17.08 14.19 48.46 45.12
Net margin -291.53% -8.24% -10.44% 5.65% 15.83% 12.71%
EPS 2 -89.95 -3.504 -2.900 1.670 4.847 4.510
Free Cash Flow 1 127.5 -16.48 13.41 -18.24 65.75 43.22
FCF margin 70.08% -6.56% 8.2% -7.27% 21.48% 12.18%
FCF Conversion (EBITDA) - - - - 114.69% 76.45%
FCF Conversion (Net income) - - - - 135.67% 95.8%
Dividend per Share - - - - - -
Announcement Date 10/21/18 10/14/19 9/7/20 9/6/21 9/7/22 9/6/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 579 478 486 459 56.5 21.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.114 x -27.46 x -146.4 x 21.26 x 0.9862 x 0.3875 x
Free Cash Flow 1 128 -16.5 13.4 -18.2 65.8 43.2
ROE (net income / shareholders' equity) 172% 4.13% 3.55% -3.03% -18.5% -84.7%
ROA (Net income/ Total Assets) -77.8% -8.47% -5.22% 4.64% 16.2% 15.2%
Assets 1 681.9 244 327.2 305.6 300 297.7
Book Value Per Share 2 -89.60 -80.00 -82.90 -52.80 -7.580 -3.070
Cash Flow per Share 2 0.0500 0.4000 0.4500 0.2100 0.3400 0.3000
Capex 1 2.02 - 1.28 4.34 6.83 11
Capex / Sales 1.11% - 0.78% 1.73% 2.23% 3.09%
Announcement Date 10/21/18 10/14/19 9/7/20 9/6/21 9/7/22 9/6/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SANJIVANI PARANTERAL LIMITED Stock Sanjivani Paranteral Limited
+2.25% 26.22M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.14% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.56% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.01% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.22% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.61% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SANJIVIN Stock
  4. Financials Sanjivani Paranteral Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW